Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

64
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
64
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.3K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.3K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

105
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
105
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

8.5K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.5K
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

87
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
87

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026
Same author

Genomic Prostate Score for Identifying Biologically Low-risk Disease in Patients with Prostate Cancer Undergoing Active Surveillance, Surgery, or Radiotherapy.

European urology oncology·2026
Same author

<b>mhn</b>: a Python package for analyzing cancer progression with Mutual Hazard Networks.

Bioinformatics advances·2026
Same author

Geno2pheno: recombination detection for HIV-1 and HEV subtypes.

NAR molecular medicine·2025
Same author

Integration of high-throughput proteomic data and complementary omics layers with PriOmics.

Genome research·2025
Same author

Metabolic Changes in Living Human Lymphoma Cells Intervening NAD <sup>+</sup> Metabolism as Revealed by NAD(P)H-Fluorescence Lifetime Imaging and Para-Hydrogen-Induced Polarization NMR.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025

Related Experiment Video

Updated: Mar 30, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K

Analyzing synergistic and non-synergistic interactions in signalling pathways using Boolean Nested Effect Models.

Martin Pirkl1, Elisabeth Hand2, Dieter Kube2

  • 1Statistical Bioinformatics Department, Institute of Functional Genomics, University of Regensburg, 93053 Regensburg and.

Bioinformatics (Oxford, England)
|November 20, 2015
PubMed
Summary
This summary is machine-generated.

Boolean Nested Effect Models (B-NEMs) infer cellular signaling pathways by integrating downstream effects with Boolean Networks. This novel approach accurately reconstructs signaling, resolving complex pathways like BCR signaling in lymphoma cells.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.8K
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

9.4K

Related Experiment Videos

Last Updated: Mar 30, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.8K
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

9.4K

Area of Science:

  • Molecular biology
  • Systems biology
  • Bioinformatics

Background:

  • Cellular signaling pathways are complex and challenging to map.
  • Boolean Networks infer signaling from protein activation.
  • Nested Effect Models use downstream effects but lack resolution.

Purpose of the Study:

  • Introduce Boolean Nested Effect Models (B-NEMs).
  • Combine downstream effects with Boolean Network resolution.
  • Overcome limitations of existing models for signaling pathway analysis.

Main Methods:

  • Developed Boolean Nested Effect Models (B-NEMs).
  • Applied B-NEMs to simulated data for validation.
  • Utilized B-NEMs to analyze BCR signaling in BL2 lymphoma cell lines.

Main Results:

  • B-NEMs accurately reconstruct signal flows in simulated datasets.
  • Successfully resolved BCR signaling pathways involving PI3K and TAK1 kinases.
  • Demonstrated the model's capability in real biological systems.

Conclusions:

  • B-NEMs offer a powerful new method for dissecting cellular signaling.
  • This approach enhances resolution compared to traditional Nested Effect Models.
  • Provides a framework for detailed analysis of complex signaling networks.